1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN

Autor:	M. Liu, P. Falk, Eric Hughes, D. J. Mcphee, Dennis Hernandez, P. Fracasso, J. Lemm, M. Kirk, E. Cooney, M. Gao
Rok vydání:	2012
Předmět:	Daclatasvir Hepatology business.industry Ribavirin Virology chemistry.chemical_compound chemistry Hcv genotype 1 Genotype Medicine General hospital business Pegylated Interferon Alfa medicine.drug
Zdroj:	Journal of Hepatology. 56:S473
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(12)61206-9
Popis:	1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B F. McPhee, D. Hernandez, F. Yu, J. Ueland, K. Chayama, J. Toyota, N. Izumi, O. Yokosuka, N. Kawada, Y. Osaki, E. Hughes, H. Watanabe, H. Ishikawa, H. Kumada. Clinical Research and Development, Bristol-Myers Squibb, Wallingford, CT, USA; Hiroshima University, Hiroshima, Sapporo-Kousei General Hospital, Sapporo, Musashino Red Cross Hospital, Tokyo, Chiba University, Chiba, Osaka City University, Osaka Red Cross Hospital, Osaka, Japan; Research and Development, Bristol-Myers Squibb, Princeton, NJ, USA; Bristol-Myers KK, Toranomon Hospital, Tokyo, Japan E-mail: fiona.mcphee@bms.com
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4629e749fc6352a38aa48ef87543a815 https://doi.org/10.1016/s0168-8278(12)61206-9 Zobrazit plný text záznamu Full Text from ScienceDirect